Clinical Trial Update: Renal Sympathetic Denervation as Secondary Prevention for Patients After Percutaneous Coronary Intervention. [NA]

View source ↗

Summary

This entry reports a clinical trial investigating renal sympathetic denervation as secondary prevention after percutaneous coronary intervention in patients wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Coronary Heart Disease | NA | Status: UNKNOWN